{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T23:31:12Z","timestamp":1787614272559,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"13-14","license":[{"start":{"date-parts":[[2012,6,25]],"date-time":"2012-06-25T00:00:00Z","timestamp":1340582400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Wien Med Wochenschr"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1007\/s10354-012-0114-z","type":"journal-article","created":{"date-parts":[[2012,6,25]],"date-time":"2012-06-25T10:46:15Z","timestamp":1340621175000},"page":"292-296","source":"Crossref","is-referenced-by-count":4,"title":["Arrhythmia-associated cardiac Ca2+ cycling proteins and gene mutations","Mutationen von Proteinen des kardialen Ca2+ Stoffwechsels in der Arrhythmogenese"],"prefix":"10.1007","volume":"162","author":[{"given":"Simon","family":"Kochh\u00e4user","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Schulze-Bahr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Kirchhefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,6,25]]},"reference":[{"key":"114_CR1","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/415198a","volume":"415","author":"DM Bers","year":"2002","unstructured":"Bers DM. Cardiac excitation-contraction coupling. Nature. 2002;415:198\u2013205.","journal-title":"Nature."},{"issue":"4","key":"114_CR2","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/clpt.2011.161","volume":"90","author":"L Hadri","year":"2011","unstructured":"Hadri L, Hajjar RJ. Calcium cycling proteins and their association with heart failure. Clin Pharmacol Ther. 2011;90(4):620\u20134.","journal-title":"Clin Pharmacol Ther"},{"key":"114_CR3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.cell.2004.09.011","volume":"119","author":"I Splawski","year":"2004","unstructured":"Splawski I, Timothy KW, Decher N, Kumar P, Sachse FB, Beggs AH, et al. Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell. 2004;119:19\u201331.","journal-title":"Cell"},{"key":"114_CR4","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1161\/CIRCULATIONAHA.106.668392","volume":"15","author":"C Antzelevitch","year":"2007","unstructured":"Antzelevitch C, Pollevick GD, Cordeiro JM, Casis O, Sanguinetti MC, Aizawa Y, et al. Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death. Circulation. 2007;15:442\u20139.","journal-title":"Circulation."},{"key":"114_CR5","doi-asserted-by":"crossref","first-page":"8089","DOI":"10.1073\/pnas.0502506102","volume":"102","author":"I Splawski","year":"2005","unstructured":"Splawski I, Timothy KW, Decher N, Kumar P, Sachse FB, Beggs AH, et al. Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations. Proc Natl Acad Sci U S A. 2005;102:8089\u201396.","journal-title":"Proc Natl Acad Sci U S A."},{"key":"114_CR6","unstructured":"Splawski I, Timothy KW, Priori SG, Napolitano C, Bloise R. Timothy Syndrome. In: Pagon RA, Bird TD, Dolan CR, Stephens K, editors. Gene Reviews (Internet). Seattle: University of Washington, Seattle; 1993\u20132006 Feb 15 (updated 2011 Apr 21)."},{"issue":"4","key":"114_CR7","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.hrthm.2005.01.005","volume":"2","author":"C Antzelevitch","year":"2005","unstructured":"Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D, et al. Brugada syndrome: report of the second consensus conference. Heart Rhythm. 2005;2(4):429\u201340.","journal-title":"Heart Rhythm."},{"issue":"4","key":"114_CR8","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.yjmcc.2010.07.012","volume":"49","author":"AA Wilde","year":"2010","unstructured":"Wilde AA, Postema PG, Di Diego JM, Viskin S, Morita H, Fish JM, et al. The pathophysiological mechanism underlying Brugada syndrome: depolarization versus repolarization. J Mol Cell Cardiol. 2010;49(4):543\u201353.","journal-title":"J Mol Cell Cardiol."},{"key":"114_CR9","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0092-8674(00)80847-8","volume":"101","author":"SO Marx","year":"2000","unstructured":"Marx SO, Reiken S, Hisamatsu Y, Jayaraman T, Burkhoff D, Rosemblit N, et al. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell. 2000;101:365\u201376.","journal-title":"Cell."},{"key":"114_CR10","doi-asserted-by":"crossref","first-page":"23389","DOI":"10.1074\/jbc.272.37.23389","volume":"272","author":"L Zhang","year":"1997","unstructured":"Zhang L, Kelley J, Schmeisser G, Kobayashi YM, Jones LR. Complex formation between junctin, triadin, calsequestrin, and the ryanodine receptor. Proteins of the cardiac junctional sarcoplasmic reticulum membrane. J Biol Chem. 1997;272:23389\u201397.","journal-title":"J Biol Chem."},{"key":"114_CR11","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1016\/S0006-3495(04)74271-X","volume":"86","author":"I Gy\u00f6rke","year":"2004","unstructured":"Gy\u00f6rke I, Hester N, Jones LR, Gy\u00f6rke S. The role of calsequestrin, triadin, and junctin in conferring cardiac ryanodine receptor responsiveness to luminal calcium. Biophys J. 2004;86:2121\u20138.","journal-title":"Biophys J."},{"key":"114_CR12","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1006\/jmcc.2002.2037","volume":"34","author":"G Hasenfuss","year":"2002","unstructured":"Hasenfuss G, Pieske B. Calcium cycling in congestive heart failure. J Mol Cell Cardiol. 2002;34:951\u201369.","journal-title":"J Mol Cell Cardiol."},{"key":"114_CR13","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1161\/01.CIR.103.2.196","volume":"103","author":"SG Priori","year":"2001","unstructured":"Priori SG, Napolitano C, Tiso N, Memmi M, Vignati G, Bloise R, et al. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation. 2001;103:196\u2013200.","journal-title":"Circulation."},{"key":"114_CR14","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1086\/324565","volume":"69","author":"H Lahat","year":"2001","unstructured":"Lahat H, Pras E, Olender T, Avidan N, Ben-Asher E, Man O, et al. A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel. Am J Hum Genet. 2001;69:1378\u201384.","journal-title":"Am J Hum Genet."},{"key":"114_CR15","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.yjmcc.2010.03.006","volume":"49","author":"U Kirchhefer","year":"2010","unstructured":"Kirchhefer U, Wehrmeister D, Postma AV, Pohlentz G, Mormann M, Kucerova D,et al. The human CASQ2 mutation K206N is associated with hyperglycosylation and altered cellular calcium handling. J Mol Cell Cardiol. 2010;49:95\u2013105.","journal-title":"J Mol Cell Cardiol."},{"key":"114_CR16","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.hrthm.2011.05.020","volume":"8","author":"MJ Ackerman","year":"2011","unstructured":"Ackerman MJ, Priori SG, Willems S, et al. HRS\/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Heart Rhythm. 2011;8:1308\u201339.","journal-title":"Heart Rhythm."},{"key":"114_CR17","doi-asserted-by":"crossref","unstructured":"Roux-Buisson N, Cacheux M, Fourest-Lieuvin A, Fauconnier J, Brocard J, Denjoy I, et al. Absence of triadin, a protein of the calcium release complex, is responsible for cardiac arrhythmia with sudden death in human. Hum Mol Genet. 2012;21(12):2759\u201367.","DOI":"10.1093\/hmg\/dds104"},{"key":"114_CR18","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1161\/01.RES.0000091335.07574.86","volume":"93","author":"CH George","year":"2003","unstructured":"George CH, Higgs GV, Lai FA. Ryanodine receptor mutations associated with stress-induced ventricular tachycardia mediate increased calcium release in stimulated cardiomyocytes. Circ Res. 2003;93:531\u201340.","journal-title":"Circ Res."},{"key":"114_CR19","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.cardiores.2004.09.009","volume":"64","author":"TD Houle","year":"2004","unstructured":"Houle TD, Ram ML, Cala SE. Calsequestrin mutant D307H exhibits depressed binding to its protein targets and a depressed response to calcium. Cardiovasc Res. 2004;64:227\u201333.","journal-title":"Cardiovasc Res."},{"key":"114_CR20","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cardiores.2007.03.002","volume":"75","author":"WP Dirksen","year":"2007","unstructured":"Dirksen WP, Lacombe VA, Chi M, Kalyanasundaram A, Viatchenko-Karpinski S, Terentyev D, et al. A mutation in calsequestrin, CASQ2D307H, impairs Sarcoplasmic Reticulum Ca2+ handling and causes complex ventricular arrhythmias in mice. Cardiovasc Res. 2007;75:69\u201378.","journal-title":"Cardiovasc Res."},{"key":"114_CR21","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1161\/01.RES.0000028455.36940.5E","volume":"91","author":"D Jiang","year":"2002","unstructured":"Jiang D, Xiao B, Zhang L, Chen SR. Enhanced basal activity of a cardiac Ca2+ release channel (ryanodine receptor) mutant associated with ventricular tachycardia and sudden death. Circ Res. 2002;91:218\u201325.","journal-title":"Circ Res."},{"key":"114_CR22","first-page":"H1796","volume":"258","author":"SG Priori","year":"1990","unstructured":"Priori SG, Corr PB. Mechanisms underlying early and delayed afterdepolarizations induced by catecholamines. Am J Physiol. 1990;258:H1796\u2013805.","journal-title":"Am J Physiol."},{"key":"114_CR23","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1136\/jmg.2004.028993","volume":"42","author":"AV Postma","year":"2005","unstructured":"Postma AV, Denjoy I, Kamblock J, Alders M, Lupoglazoff JM, Vaksmann G, et al. Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients. J Med Genet. 2005;42:863\u201370.","journal-title":"J Med Genet."},{"key":"114_CR24","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/01.CIR.0000020013.73106.D8","volume":"106","author":"SG Priori","year":"2002","unstructured":"Priori SG, Napolitano C, Memmi M, Colombi B, Drago F, Gasparini M, et al. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation. 2002;106:69\u201374.","journal-title":"Circulation."},{"key":"114_CR25","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1001\/jama.292.11.1341","volume":"292","author":"SG Priori","year":"2004","unstructured":"Priori SG, Napolitano C, Schwartz PJ, Grillo M, Bloise R, Ronchetti E, et al. Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers. JAMA. 2004;292:1341\u20134.","journal-title":"JAMA."},{"key":"114_CR26","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1161\/01.CIR.91.5.1512","volume":"91","author":"A Leenhardt","year":"1995","unstructured":"Leenhardt A, Lucet V, Denjoy I, Grau F, Ngoc DD, Coumel P. Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients. Circulation. 1995;91:1512\u20139.","journal-title":"Circulation."},{"key":"114_CR27","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1046\/j.1540-8167.2005.40516.x","volume":"16","author":"H Swan","year":"2005","unstructured":"Swan H, Laitinen P, Kontula K, Toivonen L. Calcium channel antagonism reduces exercise-induced ventricular arrhythmias in catecholaminergic polymorphic ventricular tachycardia patients with RyR2 mutations. J Cardiovasc Electrophysiol. 2005;16:162\u20136.","journal-title":"J Cardiovasc Electrophysiol."},{"key":"114_CR28","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1136\/heart.89.1.66","volume":"89","author":"N Sumitomo","year":"2003","unstructured":"Sumitomo N, Harada K, Nagashima M, Yasuda T, Nakamura Y, Aragaki Y, et al. Catecholaminergic polymorphic ventricular tachycardia: electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death. Heart. 2003;89:66\u201370.","journal-title":"Heart."},{"key":"114_CR29","doi-asserted-by":"crossref","first-page":"e385","DOI":"10.1161\/CIRCULATIONAHA.106.178233","volume":"114","author":"DP Zipes","year":"2006","unstructured":"Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, et al. ACC\/AHA\/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Circulation. 2006;114:e385\u2013484.","journal-title":"Circulation."},{"key":"114_CR30","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nm.1942","volume":"15","author":"H Watanabe","year":"2009","unstructured":"Watanabe H, Chopra N, Laver D, Hwang HS, Davies SS, Roach DE, et al. Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans. Nat Med. 2009;15:380\u20133.","journal-title":"Nat Med."}],"container-title":["Wiener Medizinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-012-0114-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10354-012-0114-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-012-0114-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T16:11:04Z","timestamp":1559146264000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10354-012-0114-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,25]]},"references-count":30,"journal-issue":{"issue":"13-14","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["114"],"URL":"https:\/\/doi.org\/10.1007\/s10354-012-0114-z","relation":{},"ISSN":["0043-5341","1563-258X"],"issn-type":[{"value":"0043-5341","type":"print"},{"value":"1563-258X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,25]]}}}